Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FluMist Reimbursement Is Ahead Of Plan; TV Ads Will Begin Sept. 29

Executive Summary

The initial coverage decisions for the FluMist nasal flu vaccine indicate that MedImmune and Wyeth will be able to maintain the $46 per dose price of the vaccine

You may also be interested in...



MedImmune Aims To Double Pharmacies Offering FluMist; WalMart Passes

MedImmune's FluMist will be available in several chain drug stores in 2003, including Safeway, Kroger's and Albertson's, even though WalMart has reversed course on offering the intranasal flu vaccine

MedImmune Aims To Double Pharmacies Offering FluMist; WalMart Passes

MedImmune's FluMist will be available in several chain drug stores in 2003, including Safeway, Kroger's and Albertson's, even though WalMart has reversed course on offering the intranasal flu vaccine

Aventis Pegs Injectable Flu Vaccine As Key Sales Growth Driver

Aventis Pasteur sees increased utilization of its injectable influenza vaccine as a key sales driver for the company going forward

Related Content

UsernamePublicRestriction

Register

LL005491

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel